DK4536686T3 - Peptidmodificeret aav-kapsel med forbedret muskeltransduktionseffektivitet - Google Patents

Peptidmodificeret aav-kapsel med forbedret muskeltransduktionseffektivitet

Info

Publication number
DK4536686T3
DK4536686T3 DK23728832.9T DK23728832T DK4536686T3 DK 4536686 T3 DK4536686 T3 DK 4536686T3 DK 23728832 T DK23728832 T DK 23728832T DK 4536686 T3 DK4536686 T3 DK 4536686T3
Authority
DK
Denmark
Prior art keywords
capsule
peptide
transduction efficiency
modified aav
improved muscle
Prior art date
Application number
DK23728832.9T
Other languages
English (en)
Inventor
Isabelle Richard
Ai Vu Hong
Original Assignee
Genethon
Inst Nat Sante Rech Med
Univ Devry Val Dessonne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genethon, Inst Nat Sante Rech Med, Univ Devry Val Dessonne filed Critical Genethon
Application granted granted Critical
Publication of DK4536686T3 publication Critical patent/DK4536686T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14145—Special targeting system for viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Manufacturing & Machinery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK23728832.9T 2022-06-10 2023-06-09 Peptidmodificeret aav-kapsel med forbedret muskeltransduktionseffektivitet DK4536686T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22305845 2022-06-10
PCT/EP2023/065499 WO2023237748A1 (en) 2022-06-10 2023-06-09 Peptide-modified aav capsid with enhanced muscle transduction efficiency

Publications (1)

Publication Number Publication Date
DK4536686T3 true DK4536686T3 (da) 2025-12-22

Family

ID=82482893

Family Applications (1)

Application Number Title Priority Date Filing Date
DK23728832.9T DK4536686T3 (da) 2022-06-10 2023-06-09 Peptidmodificeret aav-kapsel med forbedret muskeltransduktionseffektivitet

Country Status (10)

Country Link
EP (2) EP4707399A2 (da)
JP (1) JP2025519578A (da)
CN (1) CN119403823A (da)
CA (1) CA3257637A1 (da)
DK (1) DK4536686T3 (da)
ES (1) ES3057171T3 (da)
FI (1) FI4536686T3 (da)
PL (1) PL4536686T3 (da)
PT (1) PT4536686T (da)
WO (1) WO2023237748A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025133247A1 (en) 2023-12-21 2025-06-26 Genethon Methods for aav vector re-administration
WO2026017727A1 (en) 2024-07-16 2026-01-22 Genethon Alternative barcoding method to assess transduction efficiency of aav vectors
WO2026041758A1 (en) 2024-08-22 2026-02-26 Genethon Modified aav capsid with enhanced transduction efficiency
CN121203037A (zh) * 2025-09-26 2025-12-26 北京因诺惟康医药科技有限公司 基于整合素改造的特异性靶向心脏及肌肉的aav9优势突变体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA51353B1 (fr) 2018-04-05 2022-09-30 Univ Sorbonne Sérotype du virus adéno-associé recombinant hybride entre aav9 et aavrh74 possédant un tropisme hépatique réduit
JP2021521833A (ja) 2018-04-27 2021-08-30 ウニベルジテート ハイデルベルク 筋疾患の治療のための改変ａａｖカプシドポリペプチド
CA3183530A1 (en) * 2020-07-22 2022-01-27 Pardis SABETI Engineered muscle targeting compositions
JP7834725B2 (ja) 2020-09-10 2026-03-24 ジェネトン ペプチド改変されたａａｖカプシド

Also Published As

Publication number Publication date
PL4536686T3 (pl) 2026-03-23
EP4536686B1 (en) 2025-11-19
WO2023237748A1 (en) 2023-12-14
ES3057171T3 (en) 2026-02-26
CA3257637A1 (en) 2023-12-14
EP4707399A2 (en) 2026-03-11
PT4536686T (pt) 2025-12-26
EP4536686A1 (en) 2025-04-16
FI4536686T3 (fi) 2026-01-13
JP2025519578A (ja) 2025-06-26
CN119403823A (zh) 2025-02-07

Similar Documents

Publication Publication Date Title
DK4536686T3 (da) Peptidmodificeret aav-kapsel med forbedret muskeltransduktionseffektivitet
JP1747355S (ja) 筋肉マッサージ器
JP1721421S (ja) ヘアーブラシのパドル形状部
JP1754186S (ja) ヘアブラシ
IL314929A (en) Flywheel
EP4171722C0 (en) ARTIFICIAL HEART MUSCLE
EP4497435A4 (en) SKELETAL MUSCLE STRENGTHENING AGENT
IT202200015987A1 (it) Macchina per esercizi
IT202200015978A1 (it) Macchina per esercizi
EP4388934A4 (en) VIBRATING TOOTHBRUSH
JP1747377S (ja) 筋肉マッサージ器
JP1743141S (ja) 筋肉マッサージ器
JP1745997S (ja) 筋肉マッサージ器のヘッド
JP1747279S (ja) 筋肉マッサージ器のヘッド
JP1745988S (ja) 筋肉マッサージ器のヘッド
JP1709518S (ja) 筋肉マッサージ器
JP1815142S (ja) 筋肉マッサージ器
JP1815132S (ja) 筋肉マッサージ器
JP1799378S (ja) 筋肉マッサージ器
JP1801588S (ja) 筋肉マッサージ器
JP1755642S (ja) ダンベル
JP1739482S (ja) ダンベル
JP1726444S (ja) ダンベル
JP1807951S (ja) マッサージ用ブラシ
JP1776258S (ja) ヘアブラシ